The 44th J.P. Morgan Healthcare Conference will be held from January 12 to 15 in San Francisco, United States. As one of the most influential annual events in the global healthcare sector, the JPM Conference is widely regarded as a key window for the global capital markets to observe trends in pharmaceutical innovation and industry development. Dr. Jason Zhu, Executive Director and Chief Executive Officer of Henlius (2696.HK), will deliver a corporate presentation on January 15 (PST), during which he will systematically share the Company’s latest progress and long-term vision with international investors and industry stakeholders, focusing on Henlius’ Globalization 2.0 strategy, innovation pipeline layout, and mid- to long-term strategic planning.
In recent years, Henlius has continued to advance its global expansion, building an integrated biopharmaceutical platform spanning R&D, regulatory affairs, manufacturing, and commercialisation. With increasingly mature global clinical operations and manufacturing systems, multiple products have been successfully launched across international markets, while the Company’s innovation pipeline continues to accelerate towards clinical development and commercialisation. At the JPM Conference, Henlius will further elaborate on how it aims to unlock the value of its innovation assets on the foundation of robust global operations, driving sustainable and replicable international growth.
You may access the live webcast of the presentation by visiting the “Investor Relations – Investor Presentations – The 44th J.P. Morgan Healthcare Conference” section on the Henlius website, or by clicking the link below. A replay will be available for up to 30 days following the presentation.
https://jpmorgan.metameetings.net/events/healthcare26/sessions/317713-shanghai-henlius-biotech-inc/webcast?gpu_only=true&kiosk=true
Please stay tuned for key highlights and post-conference insights.